Skip to content
Home/Companies/Healthcare/XyloCor Therapeutics
XyloCor Therapeutics

XyloCor Therapeutics

Healthcare·US·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns XyloCor Therapeutics?

XyloCor Therapeutics is currently owned by Jeito Capital through Jeito II (2026 vintage), since 2024.

Hand-verified · updated 2026-04-21

Jeito Capital
Investor
Jeito Capital
Jeito II · 2026 · VC

Key facts

HQFrance
SectorHealthcare
Websitewww.xylocor.com

More from Jeito II

Other portfolio companies in the same fund.

Adcendo
Adcendo
Active
BiotechDenmark· 2026
Alveus Therapeutics
Alveus Therapeutics
Active
BiotechUS· 2026
Bionyra Pharma
Active
BiotechFrance· 2026
Augustine Therapeutics
Augustine Therapeutics
Active
BiotechBelgium· 2025
Azafaros
Azafaros
Active
BiotechNetherlands· 2025
Callio Therapeutics
Active
BiotechUS· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track XyloCor Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy XyloCor Therapeutics?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on XyloCor Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue